{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T18:23:45Z","timestamp":1778091825818,"version":"3.51.4"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To investigate the potential causal relationship between type 1 diabetes mellitus (T1DM) and IgA nephropathy (IgAN) to deepen understanding of the association between these two conditions and to provide a scientific basis for future preventive and therapeutic strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study employed Mendelian randomization (MR) analysis, using single nucleotide polymorphisms (SNPs) derived from genome-wide association studies (GWAS) as genetic instrumental variables (IVs), to assess the association between T1DM and IgAN. The analytical approaches included univariable and multivariable MR, along with sensitivity analyses such as Mendelian randomization-Egger (MR-Egger) and Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO), to evaluate the impact of heterogeneity and pleiotropy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Univariable MR analysis using the IVW method revealed an odds ratio (OR) of 1.009 [95% confidence interval (CI): 1.032\u20131.206] for the association between T1DM and IgAN. Adjusted results from multivariable MR analysis indicated a significant relationship between T1DM and increased risk of IgAN; for example, after adjusting for triglycerides (TG), the OR was 1.534 (CI: 1.213\u20131.543). After adjustment for HOMA-IR, the OR was 1.303 (CI: 1.149\u20131.198). Sensitivity analyses, including MR-Egger regression intercept testing (<jats:italic>p<\/jats:italic>\u202f=\u202f0.476), suggested no pleiotropy, and MR-PRESSO did not detect any influence from outlier SNPs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The findings suggest that T1DM is a factor in increasing the risk of IgAN, enhancing our understanding of the potential relationship between T1DM and IgAN and providing possible biological pathways for future disease prevention and intervention.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1429369","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T15:53:18Z","timestamp":1734537198000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The association between type 1 diabetes mellitus and the risk of immunoglobulin A nephropathy: a Mendelian randomization study"],"prefix":"10.3389","volume":"11","author":[{"given":"Chun-Hua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Mei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"669954","DOI":"10.3389\/fendo.2021.669954","article-title":"Evidence of early diabetic nephropathy in pediatric type 1 diabetes","volume":"12","author":"Mamilly","year":"2021","journal-title":"Front Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.3389\/fimmu.2020.02068","article-title":"Association between galactose-deficient IgA1 derived from the tonsils and recurrence of IgA nephropathy in patients who underwent kidney transplantation","volume":"11","author":"Kawabe","year":"2020","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.2215\/CJN.14031119","article-title":"GWAS-based discoveries in IgA nephropathy, membranous nephropathy, and steroid-sensitive nephrotic syndrome","volume":"16","author":"Sanchez-Rodriguez","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2215\/CJN.00910121","article-title":"Recurrence of IgA nephropathy after kidney transplantation in adults","volume":"16","author":"Uffing","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"107880","DOI":"10.1016\/j.jdiacomp.2021.107880","article-title":"Relationships between inflammation, hemodynamic function and RAAS in longstanding type 1 diabetes and diabetic kidney disease","volume":"35","author":"Ambinathan","year":"2021","journal-title":"J Diabetes Complicat"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00125-021-05584-3","article-title":"Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2,670 individuals with type 1 diabetes","volume":"65","author":"Mutter","year":"2022","journal-title":"Diabetologia"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/joim.13298","article-title":"Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes","volume":"290","author":"Jansson Sigfrids","year":"2021","journal-title":"J Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"20230877","DOI":"10.1515\/med-2023-0877","article-title":"The causal relationship between immune cells and different kidney diseases: a Mendelian randomization study","volume":"18","author":"Pang","year":"2023","journal-title":"Open Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12864-023-09633-6","article-title":"Causal associations between thyroid cancer and IgA nephropathy: a Mendelian randomization study","volume":"24","author":"Mei","year":"2023","journal-title":"BMC Genomics"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1093\/ndt\/gfi067","article-title":"Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function","volume":"20","author":"Nelson","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Davey Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.2337\/dc20-3104","article-title":"Associations of microvascular complications with the risk of cardiovascular disease in type 1 diabetes","volume":"44","author":"Gubitosi-Klug","year":"2021","journal-title":"Diabetes Care"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3118","article-title":"Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens","volume":"46","author":"Kiryluk","year":"2014","journal-title":"Nat Genet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"890273","DOI":"10.3389\/fendo.2022.890273","article-title":"Association between globulin and diabetic nephropathy in type 2 diabetes mellitus patients: a cross-sectional study","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e2720","DOI":"10.1210\/clinem\/dgab090","article-title":"Acute kidney injury and renal tubular damage in children with type 1 diabetes mellitus onset","volume":"106","author":"Marzuillo","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1681\/ASN.2020030349","article-title":"Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy","volume":"32","author":"Canney","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"700224","DOI":"10.3389\/fimmu.2021.700224","article-title":"High neutrophil-to-lymphocyte ratio is an independent risk factor for end stage renal diseases in IgA nephropathy","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.3390\/nu15102407","article-title":"The effects of specific gut microbiota and metabolites on IgA nephropathy-based on Mendelian randomization and clinical validation","volume":"15","author":"Wang","year":"2023","journal-title":"Nutrients"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1332757","DOI":"10.3389\/fimmu.2024.1332757","article-title":"Causal relationship between gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization study","volume":"15","author":"Yan","year":"2024","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12920-023-01644-2","article-title":"Does inflammatory bowel disease promote kidney diseases: a Mendelian randomization study with populations of European ancestry","volume":"16","author":"Lian","year":"2023","journal-title":"BMC Med Genet"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.2147\/DMSO.S452227","article-title":"IFN-\u03b3, SCF, MIP1b and IL-16 were associated with risk of diabetic nephropathy: a Mendelian randomization study","volume":"17","author":"An","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e003197","DOI":"10.1136\/bmjdrc-2022-003197","article-title":"Association of high-sensitivity C-reactive protein and diabetic nephropathy in patients with type 2 diabetes: a Mendelian randomization study","volume":"11","author":"Lin","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1191768","DOI":"10.3389\/fendo.2023.1191768","article-title":"Integrated multiple-microarray analysis and Mendelian randomization to identify novel targets involved in diabetic nephropathy","volume":"14","author":"Fan","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.ekir.2020.07.012","article-title":"IgA nephropathy genetic risk score to estimate the prevalence of IgA nephropathy in UK Biobank","volume":"5","author":"Sukcharoen","year":"2020","journal-title":"Kidney Int Rep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1038\/s41588-023-01422-x","article-title":"Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy","volume":"55","author":"Kiryluk","year":"2023","journal-title":"Nat Genet"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1429369\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T15:53:20Z","timestamp":1734537200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1429369\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":26,"alternative-id":["10.3389\/fmed.2024.1429369"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1429369","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"article-number":"1429369"}}